HomeFileCoronary disease

Coronary disease

EuroPCR 2018 | FAME 2: FFR Shows 5-Year Benefit for Hard Endpoints

After a 5-year follow-up, and for the first time, functional assessment with fractional flow reserve (FFR) showed...

EuroPCR 2018 | ORBITA: The Link Between Ischemia and Symptoms Is Still Not Entirely Understood

Invasive physiology tests used in the ORBITA trial could not predict which patients would benefit from angioplasty...

EuroPCR 2018 | SYNTAX III REVOLUTION: Excellent Correlation Between Angiography and Computerized Tomography in Patients with Left Main and Multivessel Disease

In patients with left main or three-vessel coronary disease, heart team decisions on revascularization strategy (angioplasty or...

EuroPCR 2018 | SCAAR Registry at 10 years: FFR improves decision making in the long term

The SCAAR registry aimed at showing the differences in mortality at very long term when using functional...

Maintaining Physical Activity After an Acute Myocardial Infarction Reduces Mortality

Performing a successful primary angioplasty and prescribing preventive medication without advising on the importance of keeping up...

Restenosis Does Not Seem as Benign as We Thought

Elective, uncomplicated repeat revascularization after stent restenosis is associated with higher mortality rates according to a new...

Hybrid Revascularization or Conventional Surgery: History Is Still Being Written

Hybrid revascularization seems to achieve results similar to those of conventional myocardial revascularization surgery at 5 years, although...

Constrictive Pericarditis After Pericardiocentesis

All interventional cardiologists must be able to perform a pericardiocentesis. Whether we deal with a chronic total...